Ulcerative Colitis: Entyvio Infusion Therapy for Lasting Relief
When ulcerative colitis flares keep disrupting daily life despite standard medication, gut-targeted biologic infusion therapy offers a more precise approach.
What is ulcerative colitis?
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the colon and rectum. Unlike Crohn's disease, which can affect any part of the digestive tract, UC is limited to the colon, and the inflammation stays closer to the surface of the intestinal lining.
Symptoms typically include bloody diarrhea, abdominal cramping, urgency, and fatigue, often coming in flares followed by periods of remission.
How infusion therapy helps
Entyvio (vedolizumab) is a biologic infusion therapy that works by blocking inflammatory cells from migrating into the gut specifically, giving it a more gut-targeted mechanism than some other biologics that affect the immune system more broadly.
Infusions are given at weeks 0, 2, and 6, then every 8 weeks for maintenance, and many patients experience both symptom relief and healing of the colon lining with consistent treatment.
Managing ulcerative colitis flares?
Our physician-led team coordinates Entyvio infusion therapy with your gastroenterologist.
Call (551) 336-5580This article is for general educational purposes and is not a substitute for medical advice. Treatment decisions should always be made with your physician based on your individual diagnosis and health history.